Skip to Main Content

Paper Details

Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Nat Commun
0
2022
SARS-CoV-2
Author NameAffiliation
Hongjie XiaUniversity of Texas Medical Branch
Jessica A PlanteUniversity of Texas Medical Branch
Jessica A PlanteWorld Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch
Jessica A PlanteInstitute for Human Infections and Immunity, University of Texas Medical Branch
Vineet D MenacheryUniversity of Texas Medical Branch
Vineet D MenacheryInstitute for Human Infections and Immunity, University of Texas Medical Branch
Kenneth S PlanteUniversity of Texas Medical Branch
Kenneth S PlanteWorld Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch
Kenneth S PlanteInstitute for Human Infections and Immunity, University of Texas Medical Branch
Kenneth S PlanteUniversity of Texas Medical Branch
Kenneth S PlanteInstitute for Human Infections and Immunity, University of Texas Medical Branch
Kenneth S PlanteWorld Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch
Xuping XieUniversity of Texas Medical Branch
Pei-Yong ShiUniversity of Texas Medical Branch
Pei-Yong ShiInstitute for Human Infections and Immunity, University of Texas Medical Branch
Pei-Yong ShiSealy Institute for Vaccine Sciences, University of Texas Medical Branch
Pei-Yong ShiSealy Institute for Drug Discovery, University of Texas Medical Branch
Pei-Yong ShiSealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch
  • 1 - 18

Datasets